Skip to main content

Table 3 C-indexes of the predictive model for patients with ASC

From: A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma

Cohort

C-indexes

Adjusted C-indexes

 

3-year

5-year

3-year

5-year

Training cohort

 LC-SM

0.83 (CI, 0.78–0.87)

0.82 (CI, 0.73–0.90)

  

Validation cohort

 LC-SM

0.79 (CI, 0.75–0.84)

0.79 (CI, 0.71–0.88)

  

Overall cohort

 LC-SM

  

0.81 (CI, 0.80–0.83)

0.81 (CI, 0.80–0.83)

  1. Note: Adjusted C-indexes of the model were calculated using ten-fold cross validation
  2. Abbreviations: ASC adenosquamous carcinoma, CI confidence interval, LC-SM lung cancer-specific mortality